Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
US Army
McKesson
Teva
Mallinckrodt
Colorcon
Boehringer Ingelheim
Citi
Medtronic

Generated: April 20, 2018

DrugPatentWatch Database Preview

METHAZOLAMIDE Drug Profile

« Back to Dashboard

When do Methazolamide patents expire, and what generic alternatives are available?

Methazolamide is a drug marketed by Ani Pharms Inc, Applied Anal, Mikart, and Sandoz. and is included in five NDAs.

The generic ingredient in METHAZOLAMIDE is methazolamide. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the methazolamide profile page.
Drug patent expirations by year for METHAZOLAMIDE
Medical Subject Heading (MeSH) Categories for METHAZOLAMIDE
Synonyms for METHAZOLAMIDE
1164547-86-7
2-Acetylimino-3-methyl-.delta.(4)-1,3,4-thiadiazoline-5-sulfonamide
2-Acetylimino-3-methyl-delta(sup 4)-1,3,4-thiadiazoline-5-sulfonamide
3-methyl-2-(2-oxo-1-azapropylidene)-1,3,4-thiadiazoline-5-sulfonamide
4-27-00-08221 (Beilstein Handbook Reference)
5-Acetylimino-4-methyl-.delta.(2)-1,3,4-thiadiazoline-2-sulfonamide
5-Acetylimino-4-methyl-| currency2-1,3,4-thiadiazoline-2-sulfonamide
5-Acetylimino-4-methyl-delta(sup 2)-1,3,4-thiadiazoline-2-sulfonamide
554-57-4
554M574
A4364
A830656
AB00052336_04
AB0013250
AB00490015
AC1L1HEV
AC1Q40D8
AC1Q40D9
Acetamide, N-(4-methyl-2-sulfamoyl-.delta.2-1,3,4-thiadiazolin-5-ylidene)-
Acetamide, N-(4-methyl-2-sulfamoyl-delta(sup 2)-1,3,4-thiadiazolin-5-ylidene)-
Acetamide, N-(5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene)-
Acetamide, N-(5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene)-, (N(Z))-
Acetamide, N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]-
AK163546
AKOS015897587
AKOS024464790
AKOS026749792
AN-45878
AS-13272
BDBM10881
BDBM50013792
BPBio1_000731
BRD-K71053238-001-03-6
BRD-K71053238-001-04-4
BRN 0232387
BSPBio_000663
BSPBio_003508
C07764
C5H8N4O3S2
CAS-554-57-4
CC-30264
CCG-39321
CHEBI:6822
CHEBI:94513
CHEMBL1335656
CHEMBL19
CHEMBL288100
cid_4100
CPD001453721
CPD001496938
CS-2658
CTK8G0825
D00655
D0C2II
DA43GW06P1
DB00703
DivK1c_000582
DR000541
DSSTox_CID_3281
DSSTox_GSID_23281
DSSTox_RID_76956
DTXSID1023281
EBD27355
EINECS 209-066-7
FCH4114988
FLOSMHQXBMRNHR-DAXSKMNVSA-N
FLOSMHQXBMRNHR-QPJJXVBHSA-N
FLOSMHQXBMRNHR-UHFFFAOYSA-N
FT-0603467
GTPL6828
H773
HE352234
HMS1570B05
HMS1922M19
HMS2093A05
HMS2097B05
HMS2234L03
HMS3259H05
HMS3372G12
HMS3652E21
HMS501N04
HSDB 3269
HY-B0553
I09-1225
IDI1_000582
K-9905
KBio1_000582
KBio2_002095
KBio2_004663
KBio2_007231
KBio3_003013
KBioGR_000739
KBioSS_002095
KS-000010PT
KS-5328
L 584601
L584601
LS-10006
MCULE-1665001985
Metazolamida
Metazolamida [INN-Spanish]
Metazolamide
Metazolamide [DCIT]
Methazolamid
Methazolamide (JAN/USP/INN)
Methazolamide (MZA)
Methazolamide (oral, sustained release)
Methazolamide [INN:BAN:JAN]
Methazolamide [USP:INN:BAN:JAN]
Methazolamide, (Z)-
Methazolamide, >=98% (HPLC)
Methazolamide, MZA
Methazolamide, United States Pharmacopeia (USP) Reference Standard
Methazolamide, VETRANAL(TM), analytical standard
Methazolamidum
Methazolamidum [INN-Latin]
Methenamide
MLS000028532
MLS001146905
MolPort-001-791-152
MolPort-019-998-640
MZA3
N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide
N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)ethanamide
N-(3-methyl-5-sulfamoyl-2,3-dihydro-1,3,4-thiadiazol-2-ylidene)acetamide
N-(4-Methyl-2-sulfamoyl-.delta.2-1,3,4-thiadiazolin-5-ylidene)acetamide
N-(4-Methyl-2-sulfamoyl-| currency2-1,3,4-thiadiazolin-5-ylidene) acetamide
N-(4-Methyl-2-sulfamoyl-| currency2-1,3,4-thiadiazolin-5-ylidene)acetamide
N-(4-Methyl-2-sulfamoyl-delta(sup 2)-1,3,4-thiadiazolin-5-ylidene)acetamide
N-(5-(Aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene)acetamide #
N-[(2E)-5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
N-[(2Z)-3-methyl-5-sulfamoyl-2,3-dihydro-1,3,4-thiadiazol-2-ylidene]acetamide
N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
Naptazane
NC00618
NCGC00016508-01
NCGC00018188-01
NCGC00018188-02
NCGC00018188-03
NCGC00018188-04
NCGC00018188-05
NCGC00018188-06
NCGC00018188-07
NCGC00022950-03
NCGC00022950-04
NCGC00178022-01
NCGC00178022-02
Neptazane
Neptazane (TN)
Neptazaneat
NINDS_000582
NSC-758426
NSC758426
Opera_ID_717
Oprea1_161738
Pharmakon1600-01503252
Prestwick_1007
Prestwick0_000802
Prestwick1_000802
Prestwick2_000802
Prestwick3_000802
S4039
SAM002548986
SAM002589943
SBB037875
SBI-0051804.P002
SCHEMBL13825893
SCHEMBL24686
SCHEMBL24687
SMR000058287
SPBio_001386
SPBio_002584
Spectrum_001615
SPECTRUM1503252
Spectrum2_001543
Spectrum3_001914
Spectrum4_000190
Spectrum5_001006
SR-05000001844
SR-05000001844-3
ST081366
Tox21_110464
UNII-DA43GW06P1
UNII-W733B0S9SD
W733B0S9SD
ZINC100019188
ZINC12503151
ZINC253917094

US Patents and Regulatory Information for METHAZOLAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc METHAZOLAMIDE methazolamide TABLET;ORAL 040001-001 Jun 30, 1993 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz METHAZOLAMIDE methazolamide TABLET;ORAL 040036-001 Jun 30, 1993 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applied Anal METHAZOLAMIDE methazolamide TABLET;ORAL 040011-002 Jul 17, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz METHAZOLAMIDE methazolamide TABLET;ORAL 040102-001 Aug 28, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cipla
UBS
Cerilliant
AstraZeneca
Fish and Richardson
Daiichi Sankyo
Chubb
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.